Clinical Trials Browser

Phase 2 × HIV Infections × Etoposide × Clear all

NCT00092222 2026-03-11

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Phase 2 Active not recruiting

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT01092182 2023-04-27

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

Phase 2 Completed

194 enrolled 19 charts

Plasmablastic Lymphoma, Burkitt Lymphoma, HIV Seropositivity, HIV Infections, Lymphoma, Large B-Cell, Diffuse

NCT00000807 2021-10-28

Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy

Phase 2 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT01045889 2016-08-19

HDT-HIV

Phase 2 Completed

Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, AIDS-Related

NCT00799136 2013-09-12

CATCH

Phase 2 Completed

LymphoidSarcoma

HIV Infections, Lymphoma, AIDS-Related, Dendritic Cell Sarcoma, Interdigitating

NCT00002003 2005-06-24

Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas

Phase 2 Completed

LymphoidSarcoma

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections, Dendritic Cell Sarcoma, Interdigitating